Natural EVs in cancer therapy. a) TEX stimulate immune activation by

Download scientific diagram | Natural EVs in cancer therapy. a) TEX stimulate immune activation by boosting T‐cell expansion and function via APCs especially DC cells. DEX activate T cells by mimicking the role of APCs. b) NK‐cell‐derived EVs induce tumor cell death through FasL, perforin, and TNF‐α. c) EVs from M1 macrophages can re‐educate tumor associated macrophages from M2 to M1 phenotype, which further activates anti‐tumor immunity. d) Stem‐cell‐derived EVs inhibit the growth of tumor cells through miRNA‐mediated mechanisms. Abbreviations: DC cell, dendritic cell; DEX, dendritic cell‐derived EVs; FasL, Fas ligand; M1 EVs, M1 macrophage‐derived EVs; MHC, major histocompatibility complex; MSCs, mesenchymal stem cells; NK EVs, NK cell‐derived EVs; TCR, T cell receptor; TEX, tumor cell‐derived EVs; TNF‐α, tumor necrosis factor‐α; TNFR, tumor necrosis factor receptor. from publication: Engineered Extracellular Vesicles for Cancer Therapy | Extracellular vesicles (EVs) have emerged as a novel cell-free strategy for the treatment of many diseases including cancer. As a result of their natural properties to mediate cell-to-cell communication and their high physiochemical stability and biocompatibility, EVs are | Extracellular Vesicles, Cancer Therapy and Bioinspired | ResearchGate, the professional network for scientists.

Natural killer (NK) cell-derived extracellular-vesicle shuttled microRNAs control T cell responses

Natural EVs in cancer therapy. a) TEX stimulate immune activation by

Tumor-derived extracellular vesicles in melanoma immune response and immunotherapy - ScienceDirect

Extracellular vesicle-based therapeutics: natural versus engineered targeting and trafficking

Extracellular Vesicles in Cancer Immune Microenvironment and Cancer Immunotherapy - Xie - 2019 - Advanced Science - Wiley Online Library

Cancers, Free Full-Text

Frontiers Extracellular Vesicles: An Emerging Nanoplatform for Cancer Therapy

Role of Exosomes in the Invasion and Metastasis of Ovarian Cancer and Application Potential of Clinical Diagnosis and Treatment

Senescent T cells: a potential biomarker and target for cancer therapy - eBioMedicine

Emerging applications of extracellular vesicles in tumor therapy, Cancer Nanotechnology

Progress in Natural Compounds/siRNA Co-delivery Employing Nanovehicles for Cancer Therapy

Extracellular vesicles in immunity – Research group Susanne Gabrielsson

Extracellular vesicle contents as non-invasive biomarkers in ovarian malignancies: Molecular Therapy - Oncolytics

Immune-Cell-Derived Exosomes for Cancer Therapy